宝济药业-B(02659)拟获董事会主席刘彦君博士增持股份

智通财经05-03

智通财经APP讯，宝济药业-B(02659)发布公告，本公司收到董事会主席兼本公司控股股东集团成员刘彦君博士的通知，基于其对本集团前景及增长潜力的信心，以及其对本公司长期投资价值的认可，其拟自本公告日期起3个月内透过公开市场交易增持本公司股份。根据上市规则项下的相关最低公众持股量规定，并为确保本公司持续遵守该等规定，控股股东可收购的最高股份数目不得超过3889.39万股H股。于本公告日期，控股股东...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2632760250?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-05-03 18:57","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2632760250","market":"hk","top_or_hot":-1,"title":"宝济药业-B(02659)拟获董事会主席刘彦君博士增持股份","media":"智通财经","content":"<div>\n<p>智通财经APP讯，宝济药业-B(02659)发布公告，本公司收到董事会主席兼本公司控股股东集团成员刘彦君博士的通知，基于其对本集团前景及增长潜力的信心，以及其对本公司长期投资价值的认可，其拟自本公告日期起3个月内透过公开市场交易增持本公司股份。根据上市规则项下的相关最低公众持股量规定，并为确保本公司持续遵守该等规定，控股股东可收购的最高股份数目不得超过3889.39万股H股。于本公告日期，控股股东...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1437694.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>宝济药业-B(02659)拟获董事会主席刘彦君博士增持股份</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n宝济药业-B(02659)拟获董事会主席刘彦君博士增持股份\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-05-03 18:57 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1437694.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，宝济药业-B(02659)发布公告，本公司收到董事会主席兼本公司控股股东集团成员刘彦君博士的通知，基于其对本集团前景及增长潜力的信心，以及其对本公司长期投资价值的认可，其拟自本公告日期起3个月内透过公开市场交易增持本公司股份。根据上市规则项下的相关最低公众持股量规定，并为确保本公司持续遵守该等规定，控股股东可收购的最高股份数目不得超过3889.39万股H股。于本公告日期，控股股东...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1437694.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02659","symbol_name":"宝济药业-B","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1437694.html","article_id":"2632760250","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2632760250","pubTimestamp":1777805832,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，宝济药业-B 发布公告，本公司收到董事会主席兼本公司控股股东集团成员刘彦君博士的通知，基于其对本集团前景及增长潜力的信心，以及其对本公司长期投资价值的认可，其拟自本公告日期起3个月内透过公开市场交易增持本公司股份。于本公告日期，控股股东集团于合共2595.69万股H股及1.06亿股内资股中拥有权益，占本公司已发行股份总数约40.57%。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"02659":"宝济药业-B","BK1161":"生物科技"},"translate_title":"Baoji Pharmaceutical-B (02659) intends to be increased by Dr. Liu Yanjun, Chairman of the Board","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02659":1.5},"content_text":"智通财经APP讯，宝济药业-B(02659)发布公告，本公司收到董事会主席兼本公司控股股东集团成员刘彦君博士的通知，基于其对本集团前景及增长潜力的信心，以及其对本公司长期投资价值的认可，其拟自本公告日期起3个月内透过公开市场交易增持本公司股份。根据上市规则项下的相关最低公众持股量规定，并为确保本公司持续遵守该等规定，控股股东可收购的最高股份数目不得超过3889.39万股H股。于本公告日期，控股股东集团于合共2595.69万股H股及1.06亿股内资股中拥有权益，占本公司已发行股份总数约40.57%。根据控股股东的意向，于增持计划实施后，控股股东集团于本公司的总持股量预期不会触发香港上市公司控股股东于任何12个月期间持股权益介乎30%至50%的情况下根据《收购及合并守则》规则26作出强制要约的责任。根据本公司可得资料及就董事会所深知，预期于增持计划完成后，本公司将继续遵守上市规则第19A.28B(1)条项下的最低公众持股百分比规定。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2632760250","isCrawlerRequest":true}